1712 related articles for article (PubMed ID: 7507857)
1. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
[TBL] [Abstract][Full Text] [Related]
2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
4. Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.
Liesveld JL; Broudy VC; Harbol AW; Abboud CN
Exp Hematol; 1995 Mar; 23(3):202-9. PubMed ID: 7533098
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
6. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
7. Extensive proliferative capacity of single isolated CD34 human cord blood cells in suspension culture.
Xiao M; Broxmeyer HE; Horie M; Grigsby S; Lu L
Blood Cells; 1994; 20(2-3):455-66; discussion 466-7. PubMed ID: 7538351
[TBL] [Abstract][Full Text] [Related]
8. Expansion of cord blood progenitors and use for hemopoietic reconstitution.
Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP
Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315
[TBL] [Abstract][Full Text] [Related]
9. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
10. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
11. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
Reisbach G; Bartke I; Kempkes B; Kostka G; Ellwart J; Birner A; Thalmeier K; Mailhammer R; Bornkamm GW; Ullrich A
Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
[TBL] [Abstract][Full Text] [Related]
12. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
[TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
15. Study of early hematopoietic precursors in human cord blood.
Abboud M; Xu F; LaVia M; Laver J
Exp Hematol; 1992 Oct; 20(9):1043-7. PubMed ID: 1281782
[TBL] [Abstract][Full Text] [Related]
16. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
18. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.
Cardoso AA; Watt SM; Batard P; Li ML; Hatzfeld A; Genevier H; Hatzfeld J
Exp Hematol; 1995 May; 23(5):407-12. PubMed ID: 7536682
[TBL] [Abstract][Full Text] [Related]
19. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
20. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
Tsujino Y; Wada H; Misawa M; Kai S; Hara H
Exp Hematol; 1993 Sep; 21(10):1379-86. PubMed ID: 7689484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
